Bashar Dabbas

1.1k citations

22 papers · 559 indexed · h-index 9

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Transplantation top 10%

Papers in ⓘ

Molecular Biology 6
- Epigenetics and DNA Methylation 3
Oncology 6
- Cancer Immunotherapy and Biomarkers 3

Co-authors: Clyde D. Ford (5 shared papers)Kevin A. Strait (4 shared papers)Elizabeth H. Hammond (2 shared papers)Prashanti Reddy (6 shared papers)Matthew J. McGinniss (4 shared papers)Shareef Nahas (2 shared papers)Yin Xu (3 shared papers)Brian Kwok (5 shared papers)
Journals: Blood (8 papers)The Journal of Heart and Lung Transplantation (3 papers)Cancer Research (2 papers)Urologic Oncology Seminars and Original Investigations (1 paper)Journal of Clinical Oncology (1 paper)
Partner nations: United States Canada Switzerland

In The Last Decade

Bashar Dabbas

21 papers receiving 549 citations

Peers

Countries citing papers authored by Bashar Dabbas

Since Specialization

Citations

This map shows the geographic impact of Bashar Dabbas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bashar Dabbas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bashar Dabbas more than expected).

Fields of papers citing papers by Bashar Dabbas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bashar Dabbas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bashar Dabbas. The network helps show where Bashar Dabbas may publish in the future.

Co-authors

The 25 scholars most cited alongside Bashar Dabbas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bashar Dabbas Line = papers co-authored together Bashar Dabbas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance Blood ·Brian Kwok, Jeff Hall, John S. Witte, Yin Xu, Prashanti Reddy, Keming Lin, Rachel Flamholz, Bashar Dabbas, Aine Yung, Jenan Al-Hafidh, Emily Balmert, Christine Vaupel, Carlos Hader, Matthew J. McGinniss, Shareef Nahas, Julie Kines, Rafael Bejar	2015	213
2	Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. PubMed ·Kevin A. Strait, Bashar Dabbas, Elizabeth H. Hammond, C. Terry Warnick, Sarah J Iistrup, Clyde D. Ford	2002	65
3	Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling OncoImmunology ·Peter J. Siska, Romany Johnpulle, Alice Y. Zhou, Jennifer Bordeaux, Ju Young Kim, Bashar Dabbas, Naveen Dakappagari, Jeffrey C. Rathmell, W. Kimryn Rathmell, Alicia K. Morgans, Justin M. Balko, Douglas B. Johnson	2017	59
4	Identification of a p53 Response Element in the Promoter Region of the hMSH2 Gene Required for Expression in A2780 Ovarian Cancer Cells Journal of Biological Chemistry ·C. Terry Warnick, Bashar Dabbas, Clyde D. Ford, Kevin A. Strait	2001	46
5	Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2–related protein Bad Molecular Cancer Therapeutics ·Kevin A. Strait, C. Terry Warnick, Clyde D. Ford, Bashar Dabbas, Elizabeth H. Hammond, Sarah J. Ilstrup	2005	46
6	Utility of Histologic Parameters in Screening for Antibody-Mediated Rejection of the Cardiac Allograft: A Study of 3,170 Biopsies The Journal of Heart and Lung Transplantation ·M. Elizabeth H. Hammond, Josef Stehlik, Gregory L. Snow, Dale G. Renlund, James P. Seaman, Bashar Dabbas, Edward M. Gilbert, James C. Stringham, James W. Long, Abdallah G. Kfoury	2005	43
7	Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy Urologic Oncology Seminars and Original Investigations ·Petros Grivas, Tarek A. Bismar, A. Alva, Huei-Chung Huang, Yang Liu, Roland Seiler, Nimira Alimohamed, Liang Cheng, M. Eric Hyndman, Bashar Dabbas, Peter C. Black, Elai Davicioni, Jonathan L. Wright, Moshe Chaim Ornstein, Omar Y. Mian, Hristos Z. Kaimakliotis, Ewan A. Gibb, Yair Lotan	2019	22
8	Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab European Urology ·Andrea Necchi, Joep J. de Jong, Daniele Raggi, Alberto Briganti, Laura Marandino, Andrea Gallina, Marco Bandini, Bashar Dabbas, Elai Davicioni, Umberto Capitanio, Francesco Montorsi, Roland Seiler, Jonathan L. Wright, Yair Lotan, Peter C. Black, Ewan A. Gibb	2021	19
9	False-Positive Restaging PET Scans Involving the Spleen in Two Patients With Aggressive Non-Hodgkin Lymphoma Clinical Nuclear Medicine ·Clyde D. Ford, Frank V. Gabor, Ross Morgan, Bashar Dabbas	2006	16
10	Somatic Mutations Indicative of Clonal Hematopoiesis Are Present in a Large Fraction of Cytopenic Patients Who Lack Diagnostic Evidence of MDS Blood ·Jeff Hall, Jenan Al Hafidh, Emily Balmert, Bashar Dabbas, Christine Vaupel, Carlos Hader, Matthew J. McGinniss, Sue Beruti, Rafael Bejar	2014	7
11	Cell type-dependent regulation of hMLH1 promoter activity is influenced by the presence of multiple redundant elements. PubMed ·C. Terry Warnick, Bashar Dabbas, Sarah J. Ilstrup, Clyde D. Ford, Kevin A. Strait	2003	6
12	Next-Generation Sequencing (NGS)-Based Profiling of Idiopathic Cytopenia of Undetermined Significance (ICUS) Identifies a Subset of Patients with Genomic Similarities to Lower-Risk Myelodysplastic Syndrome (MDS) Blood ·Brian Kwok, Prashanti Reddy, Keming Lin, Rachel Flamholz, Aine Yung, Bashar Dabbas, Matthew J. McGinniss, Shareef Nahas, Julie Kines, Yin Xu	2014	4
13	Early failure of a tricuspid valve replacement with a mitral valve homograft in a heart transplant recipient The Journal of Heart and Lung Transplantation ·Rami Alharethi, Robert E. Shaddy, Donald B. Doty, Stephanie Moore, M. Elizabeth H. Hammond, Bashar Dabbas, Thomas Fuller, Dale G. Renlund	2004	2
14	Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO1 to predict outcomes to anti-PD-1 in metastatic melanoma (MM). Journal of Clinical Oncology ·Douglas B. Johnson, Jennifer Bordeaux, Ju‐Young Kim, Christine Vaupel, David L. Rimm, Thai H. Ho, Richard W. Joseph, Adil Daud, Robert M. Conry, Elizabeth Gaughan, Anastasios Dimou, Justin M. Balko, James W. Smithy, John S. Witte, Svetlana B. McKee, Nicole Dominiak, Bashar Dabbas, Jeff Hall, Naveen Dakappagari, (unknown)	2017	2
15	Cardiovascular deaths in heart transplant recipients: Does the rejection pattern matter? The Journal of Heart and Lung Transplantation ·Abdallah G. Kfoury, Josef Stehlik, Dale G. Renlund, Gregory L. Snow, Bashar Dabbas, James C. Stringham, E.M. Gilbert, M. Elizabeth H. Hammond	2005	2
16	CD5-Negative Mantle Cell Leukemia Shows Frequent 17p Deletion and Marrow Involvement Mimicking Marginal Zone Lymphoma Blood ·Yin Xu, Prashanti Reddy, Xun Li, Riem Badr, Keming Lin, Gang Xu, Bashar Dabbas	2016	2
17	Abstract 853: Novel quantitative multiplexed PD-1/PD-L1 immunohistochemistry test provides superior prediction of treatment response in melanoma patients Cancer Research ·Jennifer Bordeaux, Douglas B. Johnson, Jeffrey A. Sosman, Ju‐Young Kim, Christine Vaupel, Bashar Dabbas, Justin Cates, Jeff Hall, Jelveh Lameh, Shabnam Tangri, Naveen Dakappagari	2016	1
18	Abstract PD02-01: Her2 expression measured by AQUA analysis on BCIRG-005 and BCIRG-006 predicts the benefit of Herceptin therapy Cancer Research ·Jason Christiansen, Nashwa Barakat, Derek Murphy, DL Rimm, Bashar Dabbas, Mike Nerenberg, Sue Beruti, Emmanuel Quinaux, Joseph J. Hall, MF Press, DJ Slamon	2012	1
19	Next-Generation Sequencing Of ASXL1, TP53, RUNX1, EZH2, and ETV6 Identifies a Significant Proportion Of Lower-Risk Myelodysplastic Syndromes With Poor Prognostic Indicators Blood ·Brian Kwok, Renee L. Mohrmann, Kim Janatpour, Yin Xu, Matthew J. McGinniss, Aine Yung, Hong Drum, Keming Lin, Julie Kines, Jeffrey Tasmin, Bashar Dabbas	2013	1
20	Clinicopathologic Analysis of Calr Mutation Subtypes in Myeloproliferative Neoplasms Blood ·Yin Xu, Brian Kwok, Aine Yung, Rachel Flamholz, Zhao Wu, Bashar Dabbas, Prashanti Reddy	2015	1

About Bashar Dabbas

Bashar Dabbas is a scholar working on Molecular Biology, Oncology, Hematology, Surgery and Genetics, having authored 22 papers that have together received 559 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Epigenetics and DNA Methylation (3 papers), Transplantation: Methods and Outcomes (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (221 citations), Transplantation (36 citations), Genetics (124 citations), Cancer Research (95 citations) and Pathology and Forensic Medicine (80 citations). Bashar Dabbas has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Clyde D. Ford, Kevin A. Strait, Elizabeth H. Hammond, Prashanti Reddy, Matthew J. McGinniss, Shareef Nahas, Yin Xu, Brian Kwok, John S. Witte and Rafael Bejar. Their work appears in journals such as Blood, The Journal of Heart and Lung Transplantation, Cancer Research, Urologic Oncology Seminars and Original Investigations and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact